Skip to content
    CHWY
    Earnings call· May 2026(Q1 FY27)

    Chewy Q1 FY27 earnings call CHWY

    Jun 10, 2026 Source

    Executive summary

    Chewy Q1 FY27 — record profitability and share gains as guidance trimmed on softer consumer

    Chewy is leaning on a recurring, Autoship-anchored model to keep compounding earnings and free cash flow even as a weakening consumer pressures premiumization and discretionary attach, forcing a revenue-guide trim while the margin outlook holds. Management frames the softness as macro-driven, not share loss, and is funding health/vet-care and AI initiatives plus a newly leveraged balance sheet to widen the moat until conditions normalize.

    Highlights

    5
    • Net sales grew 7.7% YoY to ~$3.36B, outpacing the broader pet category with continued share capture

    • Record profitability: adjusted EBITDA ~$253M at a 7.5% margin, up ~130 bps YoY on >25% EBITDA flow-through

    • Autoship customer sales ~$2.83B, up over 10% YoY, reaching a record 84.4% of total net sales

    • Free cash flow ~$71M, up over 45% YoY; ~$200M of shares repurchased in the quarter

    • Nearly 200,000 net customer additions; 21.5M active customers (+3.6% YoY) with NSPAC of $597 (+4.6% YoY normalized)

    Concerns

    5
    • Full-year FY26 net-sales guide cut to $13.40B-$13.55B (~6.3%-7.5% growth) on a more challenged consumer environment

    • Incremental pressure on premiumization and discretionary product-attach rates creating a near-term NSPAC headwind

    • Active customer adds now expected toward the lower end of the 150,000-250,000 per-quarter range on new-to-Chewy softness

    • Q2 gross margin to contract modestly YoY on lapping nonrecurring FY25 MAP pricing benefit; fuel surcharges a ~mid-single-digit-million Q2 headwind

    • Modern Animal a modest adjusted-EBITDA-margin-rate drag in FY26; new $600M Term Loan B adds leverage

    Guidance & targets

    21
    CategoryTargetConfidence
    Full-year FY26 net sales
    $13.40B-$13.55B (~6.3%-7.5% YoY growth)
    high materiality
    Medium
    Q2 FY26 net sales
    $3.30B-$3.33B (~6%-7% YoY growth)
    high materiality
    Medium
    Full-year FY26 adjusted EBITDA margin
    6.6%-6.8% (~100 bps expansion at midpoint)
    high materiality
    Medium
    Full-year FY26 adjusted EBITDA (implied)
    ~$900M at guidance midpoint
    high materiality
    Medium
    Q2 FY26 adjusted EBITDA margin
    6.3%-6.4% (~50 bps expansion at midpoint)
    high materiality
    Medium
    Q2 FY26 adjusted diluted EPS
    ~$0.36
    medium materiality
    Medium
    Quarterly net active customer additions
    toward lower end of ~150,000-250,000 net adds per quarter
    high materiality
    Medium
    AI-driven efficiency benefit (FY26)
    low tens of millions of dollars
    medium materiality
    Medium
    AI-driven efficiency benefit (FY27)
    $50 million plus
    medium materiality
    Medium
    Full-year FY26 effective tax rate
    ~24%-26%
    low materiality
    Medium
    Full-year FY26 net interest expense
    ~$10M-$15M
    low materiality
    Medium
    Year-end weighted-average diluted shares outstanding
    ~420 million (lowered by 5 million)
    low materiality
    Medium
    Full-year FY26 share-based compensation (incl. related taxes)
    broadly flat year-over-year
    low materiality
    Medium
    Gross margin (full year vs Q2)
    full-year expansion; Q2 modest YoY contraction
    medium materiality
    Medium
    SmartPak FY26 net sales contribution
    ~$80 million
    medium materiality
    High
    Modern Animal FY26 net sales and EBITDA contribution
    ~$70M net sales; ~adjusted-EBITDA-dollar-neutral
    medium materiality
    Medium
    Chewy Vet Care clinic footprint (year-end) and steady-state revenue
    ~60 clinics exiting FY26; ~$290M embedded revenue at steady state
    medium materiality
    Medium
    Chewy Vet Care new clinic openings (FY26)
    10 to 12 new openings
    medium materiality
    Medium
    Long-term adjusted EBITDA margin target
    10% over time
    high materiality
    Medium
    Long-term growth relative to market
    grow ~2x or more relative to the market
    medium materiality
    Medium
    Long-term net leverage target
    below 2x adjusted EBITDA
    medium materiality
    Medium

    Operational metrics

    13
    Net sales per active customer (NSPAC)
    $597+4.6% YoY (normalized for prior-year extra week)
    Q1 FY27

    Company's headline per-customer revenue metric; expected to return to typical mid-to-high-single-digit compounding as conditions normalize.

    Active customers
    21.5 million+3.6% YoY
    Q1 FY27 (period-end)

    Funnel healthy — lower churn and strong reactivation offset by softer new-to-Chewy acquisition.

    Autoship customer sales
    $2.83 billion+10% YoY (outpacing total company growth)
    Q1 FY27

    Recurring-revenue engine reinforcing predictability and durability.

    Adjusted EBITDA
    ~$253 millionmargin +130 bps YoY
    Q1 FY27

    Non-GAAP; record quarterly profitability driven by sponsored ads, category mix, supply-chain efficiency, marketing productivity and OpEx discipline.

    Adjusted net income
    ~$180 million
    Q1 FY27

    Non-GAAP.

    Adjusted diluted EPS
    $0.43
    Q1 FY27

    Non-GAAP.

    Advertising and marketing expense
    ~$206 million6.1% of net sales; modest YoY leverage
    Q1 FY27

    Marketing discipline maintained; avoids low-ROI cash-acquisition offers.

    Sponsored ads program
    ~3% of net sales entitlementexited FY25 within the 1%-3% growth curve
    current underwriting (FY27+)

    ASR rendered 'roughly 25%' / 'midpoint of our growth curve' ambiguously; management underwrites ~3% entitlement. Helps offset fuel-surcharge pressure.

    Non-GAAP SG&A (share repurchases)
    ~$200 million
    Q1 FY27

    Capital returned via buyback during the quarter; weighted-average diluted shares guided to ~420M at year-end.

    Cash and marketable securities
    ~$520 million
    Q1 FY27 (period-end)

    Balance-sheet strength supporting investment and capital return.

    Term Loan B issuance
    $600 million
    launched subsequent to Q1 (announced on call)

    Financing action (leverage family) — raw debt balance excluded; enhances flexibility to invest and return capital.

    Chewy Vet Care year-1 NSPAC
    ~$900
    year 1 (per CVC customer)

    CVC acts as a customer-acquisition and share-of-wallet engine; existing customers who visit CVC accelerate spend.

    Pet vet/health care TAM
    ~$54 billion
    current

    Framed as one of Chewy's largest long-term opportunities; CVC/clinic initiatives expand TAM by an incremental ~$40B.

    Industry KPIs

    4
    MetricValueDetails
    Sg a OPEX ratio17.7% of net sales (~$593M non-GAAP SG&A)% of net sales
    Store count growth47 veterinary clinics (Chewy Vet Care + Modern Animal)clinics
    Gross margin drivers30.1%%
    Distribution supply chain cost economicsfulfillment productivity improvements driving down variable costs

    Product announcements

    4
    ProductTypeDetails
    Cmax (sponsored ads product)launch
    Chewy Plus (membership program)update
    Autoship product-flow / line-attach enhancementsupdate
    Enterprise AI deployment (customer service, pharmacy, fulfillment, marketing)roadmap

    Deals & partnerships

    2
    Modern Animalacquisitionnot stated (purchase price undisclosed)

    Veterinary clinic operator with above-industry unit economics and an experience-led, technology-enabled model aligned with Chewy Vet Care; accelerates CVC expansion. 2026 focus is integration into Chewy's operating and technology stacks.

    SmartPakacquisitionnot stated (purchase price undisclosed)

    Acquisition closed in the first quarter; transaction/integration costs (~$10M with Modern Animal) excluded from non-GAAP SG&A. Transcript alternately renders the name 'SmartPack'.

    Risks & headwinds

    6
    Weaker/more cautious consumer environment pressuring premiumization and discretionary product attachbegan late Q1; expected to persist near term / balance of FY26

    FY26 net-sales guide cut to $13.40B-$13.55B (~6.3%-7.5% growth); slower NSPAC growth; described as a short-term NSPAC headwind

    Mitigation: improved CRM/conversion, mobile-app engagement, lapsed-customer reactivation and churn reduction supporting net adds; conservative back-half assumptions

    Carrier fuel surcharges flowing through the P&LQ1 FY27 through balance of FY26

    low-single-digit-million impact in Q1; ~mid-single-digit-million headwind expected in Q2; similar levels assumed for the balance of the year

    Mitigation: sponsored-ads growth helping offset; ongoing SG&A discipline and operational efficiencies

    New-to-Chewy customer acquisition softnessnear term / FY26

    active customer net adds now expected toward lower end of 150,000-250,000 per quarter; new-customer acquisition modestly worse than expected

    Mitigation: healthy reactivation rates and lower churn offsetting; disciplined LTV-to-CAC marketing

    Q2 gross-margin contraction from lapping nonrecurring FY25 MAP pricing benefitQ2 FY26

    Q2 gross margin to contract modestly YoY; Q2 adjusted EBITDA margin expansion muted (~50 bps) vs Q1

    Mitigation: full-year gross-margin expansion still expected; stronger back-half YoY expansion as the item laps; SG&A leverage

    Modern Animal margin-rate dragFY26, waning through the year

    ~adjusted-EBITDA-dollar-neutral in 2026 on ~$70M revenue, creating a modest margin-rate drag skewed higher in Q2

    Mitigation: clinics highly profitable on a mature 4-wall basis; integration and synergy capture targeted for a healthier 2027

    Increased balance-sheet leverage from new Term Loan Bsubsequent to Q1 / FY26 onward

    $600M Term Loan B launched; net interest expense guided to ~$10M-$15M for FY26

    Mitigation: conservative balance-sheet policy targeting net leverage below 2x adjusted EBITDA; >$1B total liquidity maintained

    Q&A highlights

    8

    What are the puts and takes driving sequential adjusted EBITDA margin improvement into the back half?

    Q2 is 'all phasing' — SG&A stays broadly flat while gross margin follows a more normal FY23/FY24 seasonality rather than FY25's outsized Q2 jump; back half looks like the full year with SG&A delivering slightly more of the improvement and gross margin expanding YoY on sponsored ads, premiumization and a rational promo environment.

    Q2 is really just a phasing of that gross margin where 2026 looks more stable quarter-over-quarter on gross margin rate.

    asked by Nathaniel Feather · answered by Chris Deppe

    4 min read8 chapters

    Detailed Narrative

    01

    Consumer softening and the FY26 revenue-guide reset

    The consumer environment weakened in the latter part of Q1 and management no longer embeds a back-half spending acceleration, cutting FY26 net-sales guidance to $13.40B-$13.55B (~6.3%-7.5% growth). The pressure shows up as slower NSPAC growth from softer premiumization and discretionary product-attach, not hard-goods demand collapse — hard goods remained a healthy NSPAC contributor. Management attributes ~85% of the shortfall to macro and a smaller portion to two company initiatives (Autoship product-flow attach changes and enhanced digital ad bidding) whose gains were muted by the backdrop. The low end assumes the backdrop worsens; the high end assumes improvement in H2.

    02

    Record profitability and the structural margin algorithm

    Q1 adjusted EBITDA margin reached 7.5%, up ~130 bps YoY on greater-than-25% EBITDA flow-through, and full-year adjusted EBITDA margin guidance was held at 6.6%-6.8% (~$900M at midpoint) despite the revenue cut. Gross margin of 30.1% (+50 bps) was driven by sponsored ads, favorable category mix and operating discipline, and SG&A delivered ~90 bps of leverage from fulfillment productivity and early tech/AI efficiencies. Management reiterated a 10% long-term EBITDA-margin target and stressed the model needs neither outsized industry growth nor pricing inflation, reactivating some efficiency actions it had halted for H2 to protect margin durability.

    03

    Chewy Vet Care, health TAM and the Modern Animal acquisition

    Chewy frames vet/health care as a ~$54B TAM (over $40B in-clinic products and veterinary services). CVC acts as a customer-acquisition engine — ~40% of clinic customers are new to Chewy and reach a year-1 NSPAC of ~$900, with existing customers who visit CVC accelerating share-of-wallet. The Modern Animal acquisition (closed after quarter end) added 29 clinics, lifting the base from 18 at FY25 close to 47; with 10-12 organic openings planned, Chewy expects ~60 clinics exiting FY26 and ~$290M embedded steady-state revenue. Modern Animal is roughly adjusted-EBITDA-neutral in FY26, a modest margin-rate drag, with 2026 focused on integration.

    04

    AI deployment across the enterprise

    Chewy is embedding AI across customer service, pharmacy operations, fulfillment and marketing after several quarters of building foundational infrastructure, targeting a structurally lower cost to serve. It reaffirmed a low-tens-of-millions efficiency benefit in FY26, ramping more meaningfully in FY27 and beyond, and directly confirmed a prior >$50M FY27 expectation. AI-enabled productivity was cited as an early contributor to Q1 SG&A leverage.

    05

    Autoship and recurring-revenue durability

    Autoship customer sales reached ~$2.83B, up over 10% YoY and a record 84.4% of total net sales, again outpacing overall company growth and reinforcing the predictable, recurring, non-discretionary nature of the revenue base. NSPAC rose to $597 (+4.6% YoY normalized for📎 the prior-year extra week), supported by cohort maturation, health-and-wellness penetration and cross-category engagement. Management argues Chewy's value proposition — convenience, competitive pricing, trusted service and the Autoship ecosystem — becomes more relevant when consumers prioritize value.

    06

    Sponsored ads monetization

    Sponsored ads remain the primary gross-margin growth driver, with management underwriting a ~3% of-net-sales entitlement and expecting roughly 70% of that contribution to convert to the bottom line. The newly launched Cmax product lets advertisers collaborate faster and better solves cold-start challenges for new/smaller brands; ~40% of advertisers tried it and gave high marks. Sponsored ads are also helping offset persistent carrier fuel-surcharge pressure flowing through the P&L.

    07

    Capital allocation and a more leveraged balance sheet

    Q1 free cash flow was ~$71M (+45% YoY), from ~$109M operating cash flow less ~$38M capex, and Chewy repurchased ~$200M of stock while closing the SmartPak acquisition. It ended the quarter with ~$520M of cash and marketable securities and over $1B total liquidity. Subsequent to quarter end it launched a $600M Term Loan B, framing a modest amount of leverage as an appropriate evolution of the capital structure while targeting net leverage below 2x adjusted EBITDA over time, preserving flexibility to invest and return capital.

    08

    Share gains versus a cautious category and competition

    Management asserts the pressure is macro, not share loss: industry pet food/supplies impressions weakened and declined YoY while Chewy's absolute clicks rose mid-single digits across categories, with strong branded search and direct traffic. Churn improved and reactivation stayed healthy; only new-to-Chewy acquisition softened. Management sees no meaningful competitive change — including from Amazon's same-day grocery push — and characterizes the promotional environment as active but rational, with Chewy leaning into promos opportunistically early in Q1 and pulling back later to protect ROI.

    AI-generated summary of the company’s earnings call. Not investment advice.